Sec. 14.3. (a) The board shall adopt a rule under IC 4-22-2 to declare that a product is an extraction resistant or a conversion resistant form of ephedrine or pseudoephedrine.

     (b) The board, in consultation with the state police, shall find that a product is an extraction resistant or a conversion resistant form of ephedrine or pseudoephedrine if the board determines that the product does not pose a significant risk of being used in the manufacture of methamphetamine. In making its determination under this subsection, the board may receive information from the federal Drug Enforcement Administration (DEA) as to whether a product is extraction resistant or conversion resistant.

As added by P.L.4-2016, SEC.3. Amended by P.L.5-2016, SEC.5; P.L.93-2024, SEC.208.